Crop Life Science

Ahmedabad, India Founded: 2012 • Age: 14 yrs Listed
Insecticides, fungicides, herbicides, and plant health products are manufactured.

About Crop Life Science

Crop Life Science is a publicly listed company based in Ahmedabad (India) founded in 2012. Insecticides, fungicides, herbicides, and plant health products are manufactured. The company has 194 employees. Its Indian entity Crop Life Science Limited reported revenue of β‚Ή209 Cr. Crop Life Science offers products and services including Insecticides, Fungicides, Herbicides, Micro Fertilizers, and Plant Growth Regulators. Its focus areas include Food and Agriculture, Crop Inputs and Diversified.

Company details

Crop Life Science was founded in 2012 in Ahmedabad, India, and operates in the agrochemical sector. Insecticides, fungicides, herbicides, micro fertilizers, plant growth regulators, and soil health products are produced. Technical-grade agrochemicals are manufactured at sites equipped with advanced technologies for quality control. A subsidiary is dedicated to packaging solutions, supporting overall operations in the plant health industry.

  • Headquarters Ahmedabad, India
  • Employees 194
  • Stage Public
  • Sectors
    Agriculture
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website croplifescience.com
  • Social LinkedIn X Facebook
  • Legal Name Crop Life Science Ltd.
Key Metrics
  • Market Cap
    ₹162 Cr

    CLSL-ST · NSE

  • Share Price
    ₹94.30

    0.00% today

  • Revenue
    ₹207 Cr

    FY 2025-26 · +3.3% YoY

  • EBITDA
    ₹17.77 Cr

    Margin 8.6%

  • Net Profit
    ₹6.54 Cr

    FY 2025-26 · +11.0% YoY

  • P/E (TTM)
    24.7x

    P/B 1.9x

  • ROE
    8.0%

    ROCE 11.1%

  • Debt / Equity
    0.62

    Interest cover 42.4x

  • Employee Count
    194

Products & Services of Crop Life Science

Crop Life Science offers a comprehensive portfolio of products and services, including Insecticides, Fungicides, Herbicides, Micro Fertilizers, and Plant Growth Regulators.

Insecticides
Agro Chemicals

Products for controlling insects in agricultural crops

Fungicides
Agro Chemicals

Chemicals to manage fungal diseases in plants

Herbicides
Agro Chemicals

Substances used for weed control in fields

Micro Fertilizers
Fertilizers

Nutrient supplements to enhance soil fertility

Plant Growth Regulators
Agro Chemicals

Compounds to regulate and promote plant development

Soil Plant Health Products
Agro Chemicals

Items for improving overall soil and plant health

Board of directors of Crop Life Science Limited (Crop Life Science)

Crop Life Science Limited is the primary company behind Crop Life Science. The boards of the 2 registered companies of Crop Life Science currently have 10 directors; the longest-serving is Rajeshkumar Vrajlal Lunagariya, appointed in 2014. 24 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Rajeshkumar Vrajlal Lunagariya
DIN 01580748
Director13 Mar 201412 yrs 8 moHetban Spechem Limited, Crop Life Science Limited
Ashvinkumar Ravji Lunagaria
DIN 02731913
Director15 Jul 201412 yrs 4 moHetban Spechem Limited, Crop Life Science Limited
Brajesh Lakhan Lal Kaithwas
DIN 09255132
Director28 Jul 20215 yrs 3 moHetban Spechem Limited
Chunilal Samajubhai Virolia
DIN 07984858
Whole-time director10 Nov 20224 yrsCrop Life Science Limited
Rajan Ashvinbhai Lunagariya
DIN 10203025
Director27 Nov 20241 yr 11 moHetban Spechem Limited
Bansil Rajeshkumar Lunagariya
DIN 08923739
Director27 Nov 20241 yr 11 moHetban Spechem Limited
Mansukh Amarshibhai Fultariya
DIN 11023319
Director28 Mar 20251 yr 7 moHetban Spechem Limited
Sheetalben Rachit Shah
DIN 11633798
Director10 Apr 20267 moCrop Life Science Limited
Alpeshbhai Gordhanbhai Vaghasiya
DIN 11746290
Director30 Jul 20263 moCrop Life Science Limited
Pareshbhai Bhagvanbhai Parsana
DIN 11758906
Director30 Jul 20263 moCrop Life Science Limited

IPO & Listings of Crop Life Science

Crop Life Science is a publicly listed company on the NSE with ticker symbol CLSL in India, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • IPO date30 Aug 2023
  • Listed onNSE: CLSL
  • Listed entityCrop Life Science Ltd.
  • Exchange sectorProcess industries
  • ISININE00NH01017
  • Share price₹61.70 (+4.93% on the day) · 2026-10-14
  • Market capitalisation₹101 Cr
  • Price to earnings15.9
  • EPS (diluted, trailing year)₹3.87
  • Volume (last session)2,000

Financials of Crop Life Science

Exchange-reported figures of Crop Life Science Limited, the listed company behind Crop Life Science (NSE: CLSL-ST).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹207 Cr
+3.3% YoY
EBITDA
₹17.77 Cr
+8.8% YoY
Profit After Tax
₹6.54 Cr
+11.0% YoY
Net Worth
₹84.25 Cr
+8.8% YoY
Total Assets
₹146 Cr
+14.9% YoY
Total Debt
₹56.57 Cr
+27.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Income statement
Revenue207201199131
Revenue growth+3.3%+1.0%+51.3%-
EBITDA17.7716.3412.6211.79
EBITDA margin+8.6%+8.2%+6.4%+9.0%
Profit before tax9.227.788.115.61
Net profit6.545.895.674.08
Net profit margin+3.2%+2.9%+2.9%+3.1%
EPS (β‚Ή)3.873.443.513.39
Balance sheet
Total assets14612711268.03
Net worth84.2577.4571.7340.55
Total debt56.5744.3135.4026.99
Cash & bank3.480.952.390.38
Net working capital11588.1973.4652.07
Cash flow
Cash from operations(7.63)(1.50)(8.33)2.27
Cash from investing1.58(4.11)(3.42)(4.48)
Cash from financing(8.83)(6.72)13.430.52
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue207201199131102119135
Revenue growth+3.3%+1.0%+51.3%+28.6%-14.2%-12.0%-
EBITDA16.9715.8912.6311.787.718.738.26
EBITDA margin+8.2%+7.9%+6.4%+9.0%+7.6%+7.3%+6.1%
Profit before tax9.899.008.145.603.774.914.58
Net profit6.896.625.694.072.783.643.22
Net profit margin+3.3%+3.3%+2.9%+3.1%+2.7%+3.1%+2.4%
EPS (β‚Ή)4.083.863.533.392.353.092.69
Balance sheet
Total assets14312410668.0358.7552.5346.36
Net worth85.3578.2071.7440.5536.0233.1529.70
Total debt56.5744.3133.8926.9921.5218.2416.03
Cash & bank2.930.730.580.382.073.092.31
Net working capital11387.4071.1752.0745.6039.4634.37
Cash flow
Cash from operations(7.91)(1.70)(8.28)2.27(0.15)3.502.51
Cash from investing1.53(3.83)(15.89)(4.48)(1.99)(2.15)(0.74)
Cash from financing(8.83)(5.20)24.360.521.11(0.57)(2.52)

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 16 Nov 2026
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Revenue207201199131
Revenue growth+3.3%+1.0%+51.3%-
Other income1.831.022.110.80
Total expenses189184186119
Employee cost13.8612.7911.2611.29
EBITDA17.7716.3412.6211.79
EBITDA margin+8.6%+8.2%+6.4%+9.0%
Depreciation4.944.833.233.71
Interest5.444.753.393.27
Profit before tax9.227.788.115.61
Tax2.742.192.091.53
Net profit6.545.895.674.08
Net profit margin+3.2%+2.9%+2.9%+3.1%
EPS (β‚Ή)3.873.443.513.39
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Equity & liabilities
Share capital17.1417.1417.1412.00
Reserves & surplus67.1160.3154.5928.55
Shareholders' funds (net worth)84.2577.4571.7340.55
Minority interest3.763.904.190.00
Secured loans53.3440.4830.9925.27
Unsecured loans3.233.834.411.72
Total debt56.5744.3135.4026.99
Total liabilities14612711268.03
Assets
Gross block48.7252.9050.2216.07
Net block29.9938.0239.0915.58
Capital work in progress0.000.000.000.00
Investments0.640.600.000.00
Inventories70.5648.8939.8226.19
Sundry debtors74.1469.2977.2632.56
Cash & bank balances3.480.952.390.38
Loans & advances28.4823.0520.5126.43
Total current assets17714214085.56
Total current liabilities61.7253.9966.5233.49
Net working capital11588.1973.4652.07
Total assets14612711268.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Opening cash(34.24)(21.92)0.722.07
Net cash from operating activities(7.63)(1.50)(8.33)2.27
Net cash from investing activities1.58(4.11)(3.42)(4.48)
Net cash from financing activities(8.83)(6.72)13.430.52
Net change in cash(14.89)(12.32)1.67(1.69)
Closing cash3.480.952.390.38
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23
Growth
Sales growth+3.3%+1.0%+51.3%-
EBITDA growth+8.8%+29.5%+7.0%-
PBT growth+18.5%-4.1%+44.6%+9997.0%
Net income growth+11.0%+3.9%+39.0%-
Revenue CAGR (3Y)+16.4%---
EBITDA CAGR (3Y)+14.7%---
Profitability & leverage
Net income margin+3.1%+2.8%+3.0%+3.1%
Return on capital employed+11.1%+10.9%+13.1%+13.0%
Return on net worth+8.0%+7.5%+10.7%+10.0%
Debt / equity0.620.530.560.67
Long-term debt / equity0.060.100.140.16
Interest cover42.4041.2736.1040.47
Efficiency & per share
Fixed asset turnover4.083.895.998.17
Inventory turnover3.474.526.025.01
Debtors turnover2.892.743.624.03
EPS (β‚Ή)3.873.443.513.39
Dividend per share (β‚Ή)0.000.000.000.00
Book value per share (β‚Ή)49.1545.1941.8533.80
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue207201199131102119135
Revenue growth+3.3%+1.0%+51.3%+28.6%-14.2%-12.0%-
Other income1.770.982.100.800.380.570.18
Total expenses19018518611994.30110127
Employee cost13.8612.6711.2611.2910.8811.069.84
EBITDA16.9715.8912.6311.787.718.738.26
EBITDA margin+8.2%+7.9%+6.4%+9.0%+7.6%+7.3%+6.1%
Depreciation3.413.123.213.712.252.521.75
Interest5.444.753.383.272.071.872.11
Profit before tax9.899.008.145.603.774.914.58
Tax2.922.382.091.530.961.231.36
Net profit6.896.625.694.072.783.643.22
Net profit margin+3.3%+3.3%+2.9%+3.1%+2.7%+3.1%+2.4%
EPS (β‚Ή)4.083.863.533.392.353.092.69
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital17.1417.1417.1412.0012.0012.0012.00
Reserves & surplus68.2161.0654.6028.5524.0221.1517.70
Shareholders' funds (net worth)85.3578.2071.7440.5536.0233.1529.70
Secured loans53.3440.4829.6221.5017.6817.1113.41
Unsecured loans3.233.834.275.493.841.132.62
Total debt56.5744.3133.8926.9921.5218.2416.03
Total liabilities14312410668.0358.7552.5346.36
Assets
Gross block27.8432.0229.6423.2115.1516.4513.54
Net block15.6422.1421.8315.5811.2312.8712.01
Capital work in progress0.000.000.000.001.450.000.00
Investments13.1213.0812.480.000.000.000.00
Inventories70.5648.8939.8226.1922.2629.3723.00
Sundry debtors74.1469.2977.4032.5636.8626.0927.43
Cash & bank balances2.930.730.580.382.073.092.31
Loans & advances27.9922.5319.2726.4320.2414.5311.34
Total current assets17614113785.5681.4373.0864.08
Total current liabilities62.3154.0465.9033.4935.8333.6229.71
Net working capital11387.4071.1752.0745.6039.4634.37
Total assets14312410668.0358.7552.5346.36
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash(34.26)(23.53)0.382.073.092.313.05
Net cash from operating activities(7.91)(1.70)(8.28)2.27(0.15)3.502.51
Net cash from investing activities1.53(3.83)(15.89)(4.48)(1.99)(2.15)(0.74)
Net cash from financing activities(8.83)(5.20)24.360.521.11(0.57)(2.52)
Net change in cash(15.22)(10.73)0.20(1.69)(1.02)0.78(0.75)
Closing cash2.930.730.580.382.073.092.31
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+3.3%+1.0%+51.3%+28.6%-14.2%-12.0%-
EBITDA growth+6.8%+25.8%+7.2%+52.8%-11.7%+5.7%-
PBT growth+9.9%+10.6%+45.4%+48.5%-23.2%+7.2%+9997.0%
Net income growth+4.1%+16.3%+39.8%+46.4%-23.6%+13.0%-
Revenue CAGR (3Y)+16.4%+25.3%+18.6%-1.0%---
EBITDA CAGR (3Y)+12.9%+27.3%+13.1%+12.6%---
Profitability & leverage
Net income margin+3.4%+3.3%+3.1%+3.1%+2.8%+3.1%+2.4%
Return on capital employed+11.5%+12.0%+13.2%+14.0%+10.5%+13.7%+14.5%
Return on net worth+8.6%+8.8%+10.8%+10.6%+8.1%+11.8%+10.9%
Debt / equity0.620.520.540.630.570.550.54
Long-term debt / equity0.060.090.130.110.080.090.07
Interest cover40.1237.2035.8840.5237.9130.1132.41
Efficiency & per share
Fixed asset turnover6.926.517.526.846.467.939.98
Inventory turnover3.474.526.025.423.954.545.88
Debtors turnover2.892.733.613.783.244.444.93
EPS (β‚Ή)4.083.863.533.392.353.092.69
Dividend per share (β‚Ή)0.000.000.000.000.000.000.00
Book value per share (β‚Ή)49.7945.6341.8633.8030.0227.6224.75

Web traffic of Crop Life Science

The website of Crop Life Science (croplifescience.com) receives about 1.3K visits a month.

  • Monthly visits
    1.3K

    ▲ 43.9% vs previous month

Similar websites

Websites whose visitors overlap most with Crop Life Science. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
indorama.in
indorama.in
100%
#6,055,145–
perfectcropscience.com
98%
#13,226,259View details
zuari.in
96%
6.2K#3,488,282View details
agrocel.co.in
96%
#6,443,997View details
shogunorganics.com
95%
View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 21 similar websites and full traffic analytics for Crop Life Science

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 21 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Crop Inputs & Fertilizers

3 companies that operate in the same segment as Crop Life Science (Crop Inputs & Fertilizers) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Manufacturer of fertilizers, industrial chemicals, crop nutrition products, and real estate
1979Pune, Maharashtra, IndiaUSD 1.21 B1,020
Manufacturer of agrochemicals for crop protection
1991Delhi, Delhi, IndiaUSD 88.79 MUSD 222.96 M475
Agrochemicals and equipment for crop protection are manufactured.
1994Delhi, Delhi, IndiaUSD 28.03 MUSD 303.27 M1,262
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Crop Life Science

Premium access

Complete news archive for Crop Life Science

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Crop Life Science

Crop Life Science was founded in 2012.

Crop Life Science is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.

Crop Life Science has 194 employees.

The primary company behind Crop Life Science, Crop Life Science Limited, reported revenue of β‚Ή209 Cr for FY 2026, up 3% year on year.

Crop Life Science was founded in 2012 in Ahmedabad, India, and operates in the agrochemical sector. Insecticides, fungicides, herbicides, micro fertilizers, plant growth regulators, and soil health products are produced. Technical-grade agrochemicals are manufactured at sites equipped with advanced technologies for quality control. A subsidiary is dedicated to packaging solutions, supporting overall operations in the plant health industry.

Crop Life Science offers Insecticides, Fungicides, Herbicides, Micro Fertilizers, and 2 more products and services.

Yes, Crop Life Science is publicly traded on NSE under the ticker symbol CLSL.

Crop Life Science is associated with 2 legal entities: Crop Life Science Limited, Hetban Spechem Limited.

The legal entities of Crop Life Science currently have 11 directors, including Ashvinkumar Ravji Lunagaria, Rajan Ashvinbhai Lunagariya, Brajesh Lakhan Lal Kaithwas and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available